Founded with a mission to advance diagnostic testing, ProteoGenix Inc. specializes in developing and commercializing diagnostic products and laboratory services for pregnancy-related complications, such as intra-amniotic infection, sepsis, preterm birth, preeclampsia, and Down syndrome. The company offers a range of custom services including antibody services, protein expression services, and peptide synthesis, catering to both research and clinical markets.
ProteoGenix has garnered attention for its innovative approach to diagnostics and has established itself as a key player in the field of pregnancy-related health. The company’s notable achievements include the successful commercialization of several diagnostic tests that have improved prenatal care. Through strategic partnerships and investments, ProteoGenix continues to make significant strides in enhancing the accuracy and accessibility of diagnostic testing worldwide.
